 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Research > Sangamo BioSciences, Inc.
 |
Sangamo BioSciences, Inc. |
 |
 |
 |
PROFILE |
 |
Sangamo BioSciences hopes zinc fingers have the Midas touch when it comes to regulating gene expression. The company's zinc finger DNA-binding proteins (ZFPs) control gene expression (activation) and cell function. Sangamo markets its Universal Gene Recognition platform of ZFPs to the drug discovery, agricultural, biotechnology, and other industries to aid in the development of new drugs, seeds, fertilizers, and other compounds. The company has more than 20 collaborative agreements with such companies as AstraZeneca, DuPont, and Immunex. Founder and chairman Edward Lanphier II owns nearly 20% of the company.
COMPETITION |
 |
Gene Logic Inc. (GLGC)
Lynx Therapeutics, Inc. (LYNX)
Rigel Pharmaceuticals, Inc. (RIGL)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 3.40
1-Yr. Sales Growth: 54.5%
Employees: 66
Revenue per employee: $51,515.15
KEY PEOPLE |
 |
Edward O. Lanphier
CEO
Shawn K. Johnson
CFO
CONTACT INFO |
 |
501 Canal Blvd., Ste. A100
Richmond, CA 94804
US
Phone: 510-970-6000
Fax: 510-236-8951
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |